Zur Rose Group at a glance

50% 40% 30% 20% 10% 0%

(2)

CHF

ZurRose

Group Medications

Apparel

Media products(4)

Sources: OECD; Statista; Zur Rose/IQVIA; EvaluatePharma, Market sizes for 2019, includes CH, DE, ES, FR, AT, IT Notes: 1 medications include Rx and OTC & BPC, 2019, excl. VAT, CHF/EUR = 0.93036 2 Online penetration for Rx in Germany | 3 Euromonitor 2021 Data for Europe excluding Russia | 4 Media products include music, films and books

Zur Rose Group at a glance

20 % OTC & BPC

80 % Rx

Core European market: CHF 190 bn(1)

Total DE & CH: CHF 69.7 bn(2)

e-Commerce DE & CH: CHF 3.5 bn(2)

B2C sales: CHF 1.5 bn(3)

20% acute 80% chronic

Illustrative / not true to scaleSource: Insight Health 2021 (DE), BMG 2022, IQVIA 2021 (CH), Helsana Arzneimittelreport, 2016, OECD; Statista, Zur Rose estimates | 1 Market sizes for 2019, includes CH, DE, ES, FR, AT, IT EUR/CHF = 1.0811 | 2 2021 EUR/CH 1.0811 | 3 External Revenue 2021 of Segment Germany and B2C Switzerland

Um den Rest dieser Noodl zu lesen, rufen Sie bitte die Originalversion auf, und zwar hier.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Zur Rose Group AG published this content on 25 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 April 2022 08:48:08 UTC.